Biological
FluMist clinical trials
- studies test it
- 41
- open now
- 4
- in phase 3
- 6
- first study started
- 1998
Keep track of what changes. Save the FluMist studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
40 studies that test it; most in 2012 (6)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 6 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 7
- Phase 2
- 2
- Phase 3
- 6
- Phase 4
- 22
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 30
Stanford University (10) · MedImmune LLC (10) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · University of North Carolina, Chapel Hill (2) · Imperial College London (2) · Copenhagen Respiratory Research (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · University of Bergen (1)
Often tested with
Tested in the same studies.
Influenza Vaccines (9) · Intramuscular Route of Administration (1)
Studies
Open first, then newest update. How each study uses FluMist is read from its arms, and is right about nine times in ten.
Testing it · 41
- How Healthy Adults Respond to the Nasal Flu VaccineNot yet recruitingPhase 4University of Alabama at BirminghamNCT07726862Written as FluMist (Live Attenuated Influenza Vaccine)
- A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza VaccineEnrolling by invitationPhase 4Changchun BCHT Biotechnology Co.NCT07545564Written as LAIV
- GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuERecruitingNot applicableImperial College LondonNCT06620185Written as FLUENZ
- Characterizing the Human Airway Immune Response to FluMist VaccinationRecruitingPhase 4Washington University School of MedicineNCT07177417Written as FluMist
- Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)CompletedEarly Phase 1University of North Carolina, Chapel HillNCT04901455Written as LAIV
- Vaccine Pandemic Preparedness Through Airway Immunology CharacterizationActive, not recruitingEarly Phase 1Copenhagen Respiratory ResearchNCT05921448Written as Flumist
- Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza InfectionCompletedPhase 1University of California, Los AngelesNCT02597647Written as LAIV
- Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated VaccineActive, not recruitingPhase 4Jiangsu Province Centers for Disease Control and PreventionNCT07232745Written as LAIV
- Immune Response To Intranasal Influenza VaccinationActive, not recruitingNot applicableUniversity of BergenNCT01866540Written as FLUENZ
- Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and BloodWithdrawnPhase 4Stanford UniversityNCT03884296Written as FluMist
- Self-Administered Nasal Influenza Feasibility StudyCompletedPhase 4Henry M. Jackson Foundation for the Advancement of Military MedicineNCT01933048Written as FluMist
- Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and AdolescentsCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00091702Written as Cold-adapted live attenuated influenza vaccine (FluMist)
- Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)CompletedPhase 4Stanford UniversityNCT03023683Written as FluMist®
- The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and InfectionCompletedPhase 1Stanford UniversityNCT03453801Written as FluMist®
- Safety of Nasal Influenza Immunisation in Children With AsthmaCompletedPhase 4Imperial College LondonNCT02866942Written as Administration of Live attenuated influenza vaccine (LAIV)
- Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)CompletedPhase 4Stanford UniversityNCT03028974Written as FluMist®
- B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)CompletedPhase 4Stanford UniversityNCT03020498Written as FluMist
- Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and AdolescentsCompletedPhase 4Marshfield Clinic Research FoundationNCT02250274Written as LAIV
- A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).CompletedPhase 4Public Health EnglandNCT02143882Written as Fluenz
- Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4CompletedPhase 4University of MichiganNCT00538512Written as Flumist
See all 41 studies that test FluMist →
Given in every arm · 3 — FluMist is usual care beside what is tested
- The Effects of Preceding LPS Administration on the Fluenz-induced Immune ResponseCompletedNot applicableRadboud University Medical CenterNCT02642237Written as Fluenz
- Safety Study of FluMist With and Without AmpligenTerminatedPhase 1/2AIM ImmunoTech Inc.NCT01591473Written as FluMist
- Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy AdultsCompletedPhase 1Tufts Medical CenterNCT00620412Written as Influenza Virus Vaccine Live, Intranasal